Article
Vigabatrin for SCN2A R853Q Variant-Associated Infantile Epilepsy Spasms Syndrome: Limited Efficacy and Increased Risk of Vigabatrin-Associated Brain Abnormalities on MRI
2026-08-28
Abstract excerpt
<title>Abstract</title> <p> Background Infantile epilepsy spasms syndrome (IESS) caused by the <italic>SCN2A</italic> R853Q loss-of-function (LOF) mutation is refractory or resistant. Vigabatrin (VGB) is a common treatment for IESS, but it carries a risk of Vigabatrin-Associated Brain Abnormalities on MRI (VABAM). This study investigates the efficacy and safety of VGB in infants with IESS caused by the <ital...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0c709dad-132c-55ae-91a2-4cd832677cf4
- DOI
- 10.21203/rs.3.rs-10599141/v1
